Abstract We have identified a novel gene, designated KRAP (Ki-ras-induced actin-interacting protein), encoding a protein of 1,259 amino acids with coiled-coil regions and transmembrane regions, from the cDNA library of human colon cancer HCT116 cells, as one of the genes upregulated by activated Ki-ras. While KRAP was rarely expressed in normal colon epithelium, deregulated constitutive KRAP expression was observed in some other colon cancer cells. In normal tissues, KRAP was strongly expressed in pancreas and testis. Anti-KRAP polyclonal antibodies detected endogenous KRAP as the molecular size of M r 180,000, and immunofluorescence microscopy and cytochalasin E treatment revealed that KRAP was clearly associated with the actin filaments. Furthermore, KRAP was localized as a membrane-bound form with extracellular regions. These results together suggested KRAP might be involved in the regulation of filamentous actin and signals from the outside of the cells.
Introduction
Ras has been implicated in controlling cell proliferation, differentiation, and apoptosis (Barbacid 1987; Bos 1989; Almoguera et al. 1998; Bos et al. 1987; Forrester et al. 1987) . We previously established HCT116-derived cells in which activated Ki-ras was disrupted through gene targeting ) and had reported the several critical molecular mechanisms of the activated Ki-rasmediated signals in tumorigenesis utilizing these cells Allgayer et al. 1999; Okada et al. 1998; Rak et al. 1995; Baba et al. 2000; Tsunoda et al. 2002; Okumura et al. 1999) . The cleavage signal-1 protein, CS-1, a protein of 249 amino acids reported to be detected as the molecular size of M r 33,000 in Western blot using anti-CS-1 polyclonal antibodies, was originally identified as a sperm surface antigen involved in regulation of early cleavage of fertilized eggs (Javed and Naz 1992; Naz 1992 ). Here we have identified a novel gene, designated KRAP (Ki-ras-induced actin-interacting protein), including CS-1 sequences in the COOH terminal region. KRAP was overexpressed through the activated Ki-rasmediated signals in HCT116 cells, and anti-KRAP polyclonal antibodies detected endogenous KRAP as a single band of the molecular size of M r 180,000. Of great interest is that KRAP was colocalized with filamentous actin and was also localized at the cell surface.
Materials and methods

Isolation of differentially expressed genes
Isolation of differentially expressed genes between HCT116 and HKe3 cells was as described (Baba et al. 2000) . KRAP cDNA was isolated by conventional plaque hybridization from the HCT116 cDNA library, and the full length of KRAP cDNA was determined by 5Õ rapid amplification of cDNA ends. Mouse KRAP cDNA was isolated from a mouse heart cDNA library using a human KRAP cDNA as a probe, and the full length of cDNA was determined as described above. DNA sequences were determined by ABI PrismNorthern blot Total RNA of cell lines was isolated by ISOGEN (Nippon Gene, Tokyo, Japan) following the manufacturerÕs protocol. Total RNA (20 lg) was separated by electrophoresis in a 1% agarose-formaldehyde gel, transferred to nylon membrane (Pall, East Hills, NY, USA), as described (Baba et al. 2000; Tsunoda et al. 2002) . Human endocrine multiple tissue Northern (MTN) blot filter and human MTN blot II filter were purchased from Clontech (Palo Alto, CA, USA) on which 2 lg of polyA RNA from each tissue was loaded. These filters were hybridized with probes for human KRAP cDNA (full length of the coding region), and b-actin cDNAs, as described (Okumura et al. 1999 ).
Anti-KRAP polyclonal antibodies
Anti-KRAP polyclonal antibodies (FT017-2) were raised in rabbits using the polypeptide (amino acids 1,178-1,192 of human KRAP: VDAAEGAPEVVGPKS). Polyclonal antibodies were purified from serum by using protein-G Sepharose column.
Transfections and stable transfectants COOH terminal hemagglutinin (HA)-tagged (Baba et al. 2000) KRAP cDNA was subcloned into pSI vector (Promega, Madison, WI, USA). Cells were transiently transfected using Polyfect (QIAGEN, Hilden, Germany) according to the manufacturerÕs protocol. Total cell lysates were extracted 24 h after transfection then subjected to immunoblot analysis using Western blots (Okumura et al. 1999) . For stable transfectants, COOH terminal HA-tagged KRAP cDNA was subcloned into pMG vector (Invivogen, San Diego, CA, USA), and the linearized pMG-KRAP-HA was transfected into NIH3T3 cells using Polyfect. Cells maintained in DulbeccoÕs modified eagleÕs medium (DMEM) with 10% fetal calf serum (FCS) were split after 2 days, and cells were selected with 100 lg/ml of hygromycin B (Invitrogen, Carlbad, CA, USA). Colonies surviving in selection media in 14 days were picked up under the microscope and expanded and characterized for the expression of KRAP-HA by Western blot using anti-HA antibody (3F10) (Roche, Mannheim, Germany).
Immunofluorescence staining
Cells were grown on collagen-coated glass coverslips in growth medium. Twenty-four hours after transfection, cells were fixed with 3.7% paraformaldehyde in phosphate buffered saline (PBS) for 10 min at room temperature. After blocking with 1.4% milk in PBS containing 0.1% saponin, cells were incubated with anti-HA antibody (3F10) in PBS containing 0.1% bovine serum albumin (BSA) and 0.1% saponin for 1 h at room temperature, followed by incubation with Alexa Fluor 488 anti-rat IgG and/or Alexa Fluor 594 phalloidin (Molecular Probes, Eugene, OR, USA) at a dilution 1:2,000 for 1 h at room temperature. For counterstaining the nucleic acids, cells were incubated with 100 lg/mL of DNase-free RNase in 2·SSC (0.3 M NaCl, 0.03 M sodium citrate, pH7.0) followed by incubation with 500 nM solution of propidium iodide (PI) (Molecular Probes, Eugene, OR, USA) for 5 min at 37°C. Cells were covered with a drop of GEL/MOUNT (Biomeda, Foster City, CA, USA), viewed by confocal laser scanning microscopy (FLUOVIEW FV500, OLYMPUS). Pretreatment of cytochalasin E (Sigma, Deisenhofen, Germany) (100 ng/ml or 1.0 lg/ml in DMEM with 10% FCS) was done 3 h before fixing.
Surface biotinylation and immunoprecipitation
Biotinylation of cell-surface proteins was done as described (Baba et al. 2000) . The surface-biotinylated lysates of the transfected HCT116 cells (4·10 7 ) were immunoprecipitated with 2 lg/ml of anti-HA antibody for overnight at 4°C, then protein G-Sepharose was added for 2 h. Protein G-Sepharose complexes were boiled for 10 min, and the supernatants were run in a 6% SDS-PAGE. Western blots were done using streptavidin-horseradish peroxidase (SA-HRP) (Amersham Biosciences, Piscataway, NJ, USA) and anti-HA antibody (3F10).
Results
To identify the genes located downstream of the activated Ki-ras-mediating signals, a PCR-based cDNA subtraction library was constructed between HCT116 cells and HCT116-derived activated Ki-rasdisrupted clone cells (HKe3) through homologous recombination ). The KRAP cDNA fragment was detected from this subtracted library, and the full length of KRAP cDNA was isolated from the HCT116 cDNA library (Baba et al. 2000) . To confirm the differential expression of KRAP between HCT116 cells and HKe3 cells, Northern blot analysis was done under exponential condition. Northern blot detected the 5.2 kb-major KRAP transcript and the other minor 6.0 kb-KRAP transcript (Fig. 1) . KRAP was strongly expressed in HCT116, whereas it was rarely observed in HKe3 (Fig. 1A) . Furthermore, HKe3-stable transfectants expressing the activated Ki-ras (e3-MKRas#9, e3-MKRas#14) (Baba et al. 2000) evidently expressed KRAP (Fig. 1A) .
Northern blots revealed that KRAP expression was rarely evident in the normal colon epithelium, whereas it was strongly expressed in several kinds of human colon cancer cells (Fig. 1B) . On the other hand, KRAP expression in human normal tissues was strongly observed in pancreas and testis (Fig. 1C) . Human KRAP cDNA was isolated from the HCT116 cDNA library and the full length of KRAP cDNA was determined by 5Õ rapid amplification of cDNA ends (AB116937). KRAP encodes a hypothetical protein of 1,259 amino acids (a.a.) with the transmembrane (a.a.870-890) and coiled-coil regions (a.a 992-1,038) (Fig. 2) . To identify a mouse homologue of human KRAP, mouse cDNA library was screened using human KRAP cDNA fragment as a probe, and mouse KRAP cDNA encoding a protein of 1,252 a.a. was cloned (AB120565). Mouse KRAP cDNA had 81% identity with human KRAP at the nucleotides level and 86% similarity at the amino acid level (Fig. 2) .
Anti-KRAP polyclonal antibodies (FT017-2) raised in rabbits using the peptides of the COOH terminal region of KRAP (a.a.1,178-1,192), recognized a single band of the molecular size of about M r 180,000 in HCT116 and e3-MKRas#9, but barely in HKe3 (Fig. 3) . The 293T cells were transiently transfected with KRAP-HA, HA-tagged in the COOH terminal region of KRAP, and KRAP-HA was evidently detected by FT017-2 at almost the same molecular size of KRAP detected in HCT116 cells, but was not detected in the nontransfected 293T cells. Furthermore, any processed KRAP was not detected in other human cancer cell lines examined by FT017-2 (data not shown).
To elucidate the localization of KRAP in the cells, NIH3T3-derived stable transfectants expressing KRAP-HA (NIH3T3-KRAP-HA#1) were stained with anti-HA antibody. KRAP-HA seemed to be colocalized with phalloidin-specific dye for F-actin in NIH3T3-KRAP-HA#1 (Fig. 4A) , indicating that KRAP is colocalized with actin filaments. Cytochalasin E, an epoxide-containing metabolite of Aspergillus clavatus, is a compound with diverse activities on cellular function, including inhibition of actin polymerization and glucose transport (Udagawa et al. 2000) . To elucidate the interaction of KRAP with the actin filaments, treatment with cytochalasin E was done. Phalloidin staining indicated that disruption of actin filaments by cytochalasin E occurred in a dosedependent manner, and the interaction of KRAP with phalloidin gradually disappeared (Fig. 4B, C) . These results together suggested that KRAP is associated with actin filaments in NIH3T3 cells.
To determine the localization of KRAP in cancer cells, COS7 cells and HCT116 cells were transfected with KRAP-HA and were stained with anti-HA and PI, indicating that KRAP is not localized in the nucleus (Fig. 4D) . In COS7 cells, KRAP seemed to be localized near the cell membrane and the leading edge of the cells (Fig. 4E) . In HCT116 cells, KRAP seemed to be also localized near the membrane regions (Fig. 4F) . To elucidate whether KRAP exists as cell-surface protein, surface biotinylation was done, indicating that KRAP has the outer membrane region in HCT116 cells (Fig. 5) . Fig. 3 Activated Ki-ras-induced actin-interacting protein (KRAP) expression. Anti-KRAP rabbit polyclonal antibodies detected the endogenous KRAP at the molecular size of M r 180,000 (arrow). HCT116, HKe3, and HKe3-MKRas#9 cells were grown at exponential growth conditions; 293T cells were transfected with pSI-KRAP-hemagglutinin (HA) or empty vector, and then whole cell lysates were run in a 6% SDS-PAGE Fig. 4A-F Colocalization of Ki-ras-induced actin-interacting protein (KRAP) with actin filaments. A A NIH3T3-derived stable transfectant expressing human KRAP hemagglutinin (HA) (NIH3T3-KRAP-HA#1) was established. Cells were fixed and stained with anti-HA antibody (green) and phalloidin (red). Superimposed images are also shown (merge). NIH3T3-KRAP-HA#1 cells were pretreated with 100 ng/ml (B) and 1 lg/ml (C) of cytochalasin E in growth medium for 3 h. Cells were washed three times with PBS and stained with anti-HA antibody (green) and phalloidin (red). Superimposed images are also shown (merge). D COS-7 cells were transfected with pSI-KRAP-HA, and cells were grown on collagen-coated glass coverslips in growth medium. 24 h after transfection, cells were fixed and stained with anti-HA (green) and propidium iodide (PI) (red). Superimposed images are also shown (merge). COS7 cells (E) and HCT116 cells (F) were transfected with pSI-KRAP-HA and were stained with anti-HA antibody (3F10). COS7 cells were also stained with PI
Discussion
We have identified a novel gene, designated KRAP (Ki-ras-induced actin-interacting protein), encoding a protein of 1,259 amino acids with coiled-coil and transmembrane regions, from the cDNA library of human colon cancer HCT116 cells, as one of the genes upregulated by activated Ki-ras.
Although Ki-ras mutation was detected in colon cancer cell lines, including HCT116, DLD-1, HCT-15, LS180, LoVo, and SW620 (Shirasawa 1993) , KRAP was not overexpressed in LoVo cells, suggesting that other signals, in addition to the activated Ki-ras-mediated signals, might be necessary for the overexpression of KRAP. On the other hand, the colon cancer cells without Ki-ras mutation, including WiDr and Colo201 (Shirasawa 1993) , expressed evident expression of KRAP, suggesting that other signals also could induce deregulated KRAP expression in human colon cancer cells. NIH3T3-derived stable transfectants expressing KRAP did not show tumorigenicity in nude mice nor did they show soft agar colony formation (data not shown), suggesting that overexpression of KRAP itself might not be sufficient for tumorigenicity and that other additional signals might be necessary for tumorigenicity. However, deregulated expression was observed not only in colon cancer cells but also in other kinds of cancer cell lines (data not shown), suggesting that KRAP might play critical roles in tumorigenesis through collaboration with other signals.
Mouse KRAP cDNA had 81% identity with human KRAP at the nucleotides level and 86% similarity at the amino acid level, indicating that KRAP was highly conserved between human and mouse. COOH terminal regions (residues of a.a.1013-1259) of KRAP had been reported as the CS-1 (Javed and Naz 1992) . CS-1 was originally identified as a sperm surface antigen of the molecular size of M r 33,000, and anti-CS-1 polyclonal antibodies inhibited the early cleavage of fertilized eggs without affecting binding between sperm and egg or pronuclear formation (Javed and Naz 1992; Naz 1992) .
We prepared the anti-KRAP polyclonal antibodies (FT017-2) raised in rabbits using the peptides of the COOH terminal region of KRAP, which recognized a single band of the molecular size of about M r 180,000 in HCT116 cells, and processed KRAP was not detected in other human cancer cell lines examined. Although there is a possibility that CS-1 is located in the sperm surface as the molecular size of M r 33,000, all these results together suggested that KRAP is an actual protein as the molecular size of about M r 180,000.
XCS-1, Xenopus homologue of CS-1, was reported to be detected on the membrane and in the nucleus of Xenopus blastomeres, on the mitotic spindle in mitotic cells, and on the centrosomes in interphase cells (Nakamura et al. 2000) . Immunofluorescence microscopy revealed that neither KRAP nor CS-1-HA, HAtagged in the COOH terminal region of the original CS-1 (Javed and Naz 1992), was localized in the nucleus in HCT116 cells, COS-7 cells, or NIH3T3 cells (data not shown). On the other hand, immunofluorescence microscopy and cytochalasin E treatment revealed that KRAP was clearly associated with the actin filaments in NIH3T3 cells. Furthermore, immunofluorescence microscopy and surface biotinylation revealed that KRAP exists as a membrane-bound form with the extracellular region in HCT116 cells. All these results together suggest that the localization of KRAP in the cells might vary depending on the cell types or other signals involved in the regulation of KRAP.
One of the critical processes in cancer developments is migration that requires the continuous, coordinated formation and disassembly of adhesions. These processes are complex and require a coordinated interaction of actin (Pollard 2003) or actin-interacting proteins, signaling molecules, structural proteins, integrins, adaptor molecules, and microtubules (Webb et al. 2002) . Colocalization of KRAP with actin filaments and localization at the cell membranes with extracellular region suggest that KRAP might be involved in regulation of actin filaments and signals from the outside of the cells.
We have demonstrated previously that activated Ki-ras is involved in the upregulation of c-myc, VEGF, the urokinase-type plasminogen activator receptor, epiregulin, and mig-6, all of which are critically involved in tumorigenesis. Here we have identified a novel actininteracting protein, KRAP, evidently induced by acti- 
